More than US$55 billion has been invested in developing gene modification and cell therapy platforms over the past three years. While the science has advanced, the practical components of launch and optimizing commercial success are lagging behind, creating challenges across everything from stakeholder engagement and value discussions to supply chain and patient access.
In this webinar, our expert panel explore the commercial readiness challenges and practical realities of driving a successful launch in this space.
This webinar was originally recorded live June 29, 2022.
Watch the on-demand webinar now
"*" indicates required fields